Clonazepam intranasal

Drug Profile

Clonazepam intranasal

Alternative Names: JZP-8

Latest Information Update: 25 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Jazz Pharmaceuticals
  • Developer Jazz Pharmaceuticals plc
  • Class Antiepileptic drugs; Antipsychotics; Anxiolytics; Benzodiazepines; Benzodiazepinones
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Epilepsy
  • New Molecular Entity No

Highest Development Phases

  • No development reported Epilepsy

Most Recent Events

  • 25 Jun 2015 No recent reports of development identified - Phase-II for Epilepsy in Finland and USA (Intranasal)
  • 18 Jan 2012 Azur Pharma has merged with Jazz Pharmaceuticals Inc to form Jazz Pharmaceuticals plc
  • 10 Mar 2011 Jazz Pharmaceuticals is no longer actively seeking a licensing partner for clonazepam intranasal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top